.
MergerLinks Header Logo

New Deal


Announced

Mitsui and ROHTO Pharmaceutical to acquire Eu Yan Sang International from Righteous Crane for $594m.

Financials

Edit Data
Transaction Value-
Consideration TypeCash, Contingent Deferred Consideration
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

healthcare products

Acquisition

Cross Border

Pending

Majority

Private

Single Bidder

Singapore

traditional Chinese medicine

Specialty Retailers

Friendly

Private Equity

Synopsis

Edit

Mitsui, one of the largest general trading companies in Japan, and ROHTO Pharmaceutical, a multinational fast-moving consumer goods and OTC pharmaceutical corporation, agreed to acquire Eu Yan Sang International, an online store that specializes in traditional Chinese medicine products, from Righteous Crane, an investment company, for $594m. Mitsui has identified "Wellness Ecosystem Creation" as one of its key strategic initiatives in the Medium-term Management Plan 2026. Through the provision of healthcare, preventive care, and solutions for pre-symptomatic conditions, as well as the supply of foods that offer health benefits, Mitsui will contribute to the qualitative enhancement of today's increasingly diverse consumer lifestyles. Mitsui will continue to support the realization of richer and brighter lives by enhancing health and well-being through its contributions in the area of preventive care and solutions for pre-symptomatic conditions.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US